Update on the Use of Premium Intraocular Lenses in Glaucoma
Purpose of Review
In this report, we review the latest evidence for and against the use of premium intraocular lenses (IOL) in patients with glaucoma.
Visual outcomes from clinical studies of newer Extend Depth of Focus (EDF) IOLs and low add apodized diffractive-refractive IOLs are significantly better than prior generations of multifocal (MF) IOLs. Clinical studies show that EDF and monofocal IOLs have similar contrast sensitivities in photopic conditions independent of spatial frequency.
Premium IOLs restore uncorrected visual function, but intolerable visual disturbances and contrast impairment are uncommon side effects. Awareness of issues unique to glaucoma is critical for appropriate patient selection. Combined procedures with sizable shifts in IOP may have better refractive outcomes when staged. Toric and accommodating IOLs are reasonable options for most stages of glaucoma without fixation loss. EDF and newer MF IOLs can be appropriate options for stable pre-perimetric and early perimetric conditions.
KeywordsGlaucoma Premium intraocular lenses Contrast sensitivity Multifocal Extended depth of focus
Compliance with Ethical Standards
Conflict of Interest
Abayomi Fabunmi declares no potential conflicts of interest. Steven Sarkisian is a consultant/advisor for Allergen, Beaver-Visitec International, Inc., Katema Products, Inc., New World Medical Inc., Omeros, and Stanten, Inc. Dr. Sarkisian is also a consultant/advisor and has received grant support and lecture fees from Alcon Laboratories, Inc. He is also a consultant/advisor and received grant support from Glaukos Corporation. Lastly, Dr. Sarkisian is a consultant/advisor, equity owner, and received grant support from Sight Sciences, Inc.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Visser N, Beckers HJ, Bauer NJ, Gast ST, Zijlmans BL, Berenschot TT, et al. Toric vs aspherical control intraocular lenses in patients with cataract and corneal astigmatism: a randomized clinical trial. JAMA Ophthalmol. 2014;132(12):1462–8. https://doi.org/10.1001/jamaophthalmol.2014.3602.CrossRefGoogle Scholar
- 2.•• Song XD, Hao YS, Bao YZ, Li ZH, Zhang H, Yu AY, et al. A multicenter study of the effectiveness and safety of Toric intraocular lens implantation. Zhonghua Yan Ke Za Zhi. 2018;54(5):349–56. https://doi.org/10.3760/cma.j.issn.0412-4081.2018.05.008. Efficacy of toric intraocular lenses for the correction of regular astigmatism. Google Scholar
- 3.• Leyland M, et al. Multifocal versus monofocal intraocular lenses after cataract extraction. Cochrane Database Syst Rev. 2016;12:CD003169. Quantitative assessment of the benefit of multifocal compared to monofocal IOLs. Google Scholar
- 4.•• Pedrotti E, Carones F, Aiello F, Mastropasqua R. Comparative analysis of visual outcomes with 4 intraocular lenses: monofocal, multifocal, and extended range of vision. J Cataract Refract Surg. 2018;44(2):156–67. Analysis of contrast sensitivity between diffractive-refractive, monofocal, and extended depth of focus IOLs. Validated spectacle independence analysis with between diffractive-refractive, monofocal, and extended depth of focus IOLs. CrossRefGoogle Scholar
- 6.• Mencucci R, Favuzza E, Caporossi O, Savastano A, Rizzo S. Comparative analysis of visual outcomes, reading skills, contrast sensitivity, and patient satisfaction with two models of trifocal diffractive intraocular lenses and an extended range of vision intraocular lens. Graefes Arch Clin Exp Ophthalmol. 2018;256(10):1913–22. https://doi.org/10.1007/s00417-018-4052-3. Comparative analysis of visual outcomes and contrast sensitivities after implantation of an extended depth of focus IOL or a trifocal diffractive lens. CrossRefGoogle Scholar
- 7.• Savini G, Schiano-Lomoriello D, Balducci N, Barboni P. Visual performance of a new extended depth-of-focus intraocular lens compared to a distance-dominant diffractive multifocal intraocular lens. J Refract Surg. 2018;34(4):228–35. https://doi.org/10.3928/1081597X-20180125-01. Early clinical outcomes study reporting visual outcomes and contrast sensitivities after implantation of an extended depth of focus IOL compared to a distance dominant diffractive multifocal. CrossRefGoogle Scholar
- 8.• Savini G, Balducci N, Carbonara C, Rossi S, Altieri M, Frugis N, et al. Functional assessment of a new extended depth-of-focus intraocular lens. Eye (Lond). 2018. https://doi.org/10.1038/s41433-018-0221-1 Assessment of visual outcomes and contrast sensitives of a new extend depth of focus IOL.
- 10.•• Zhou H, Zhu C, Xu W, Zhou F. The efficacy of accommodative versus monofocal intraocular lenses for cataract patients: a systematic review and meta-analysis. Medicine (Baltimore). 2018;97(40):e12693. https://doi.org/10.1097/MD.0000000000012693. Efficacy of accommodative IOL compared to monfocal lenses. CrossRefGoogle Scholar
- 24.• Dyrda A, Martínez-Palmer A, Martín-Moral D, Rey A, Morilla A, Castilla-Martí M, et al. Clinical results of diffractive, refractive, hybrid multifocal, and monofocal intraocular lenses. J Ophthalmol. 2018;2018:8285637. https://doi.org/10.1155/2018/8285637 eCollection 2018. Clinical analysis of patient satisfaction with contrast sensitives among monfocal diffractive, refractive, and hybrid IOL. Google Scholar
- 25.Visser N, Beckers HJ, Bauer NJ, Gast ST, Zijlmans BL, Berenschot TT, et al. Toric vs aspherical control intraocular lenses in patients with cataract and corneal astigmatism: a randomized clinical trial. JAMA Ophthalmol. 2014;132(12):1462–8. https://doi.org/10.1001/jamaophthalmol.2014.3602.CrossRefGoogle Scholar
- 27.•• Brown RH, Zhong L, Bozeman CW, Lynch MG. Toric intraocular lens outcomes in patients with glaucoma. J Refract Surg. 2015;31(6):366–72. https://doi.org/10.3928/1081597X-20150521-02. Study showing that the visual outcomes and postoperative rotational stability of toric IOLs are similar in patient with and without glaucoma. CrossRefGoogle Scholar
- 29.•• Pakravan M, Alvani A, Esfandiari H, Ghahari E, Yaseri M. Post-trabeculectomy ocular biometric changes. Clin Exp Optom. 2017;100:128–32. Long-term changes in AL and keratometry may affect predicted refractive outcomes and may be circumvented by stage cataract surgery 6 months after filtering surgery. CrossRefGoogle Scholar
- 40.Piovella M, Colonval S, Kapp A, Reiter J, Van Cauwenberge F, Alfonso J. Patient outcomes following implantation with a trifocal toric IOL: twelve-month prospective multicentre study. Eye (Lond). 2018. https://doi.org/10.1038/s41433-018-0076-5.